On March 29th, Argentine media outlet Clarin reported that Philip Morris International (PMI) subsidiary Massalin Particulares has announced the suspension of a $300 million investment plan to produce IQOS in Argentina. This decision comes in response to Argentina's recent ban on heated tobacco products, which came into effect on March 27th.
Massalin Particulares has expressed that the Argentine Department of Health's order to prohibit the sale and promotion of heated tobacco products (PTCs) is incomprehensible and contrary to global trends. Instead of prohibition, regulation should be implemented.
According to reports, PMI operates under the name Massalin Particulares in Argentina and holds a 65% share of the cigarette market. However, PMI's heat-not-burn product IQOS has not yet officially entered the Argentine market.
As previously reported, PMI had expressed its desire for Argentina to replace traditional cigarettes with less harmful devices, such as heated non-burning devices.
Before the ban was announced, PMI had planned to invest $300 million to introduce IQOS in Argentina. Currently, PMI is only able to suspend its investment.
Tobacco company Massalin Particulares has stated that the ban on the sale of heated non-combustible products means that over 7 million adult smokers in the country will no longer have access to alternatives.
References:
【1】Philip Morris plans to stop selling cigarettes: they will be replaced by tobacco heaters. 【2】The Ministry of Health has banned the import and sale of tobacco heaters.
A multinational company has suspended a multimillion-dollar investment in the country.
Further reading:
Argentina is set to completely ban heated tobacco products.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
